Arogya Sanjeevani Policy of ManipalCigna Health Insurance, also Covers Coronavirus Treatment


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Arogya Sanjeevani Policy of ManipalCigna Health Insurance, also Covers Coronavirus Treatment
Arogya Sanjeevani Policy, ManipalCigna provides affordable all India health coverage also includes cover for modern treatments & procedures; hospitalisation coverage for infectious diseases like Coronavirus (Covid-19)

ManipalCigna Health Insurance Company Limited, a joint venture between Manipal Group, an eminent player in the field of healthcare delivery and higher education, U.S. based global health service leader, Cigna Corporation and Indian conglomerate TTK Group, recently announced the launch of its 'Arogya Sanjeevani Policy, ManipalCigna' in line with IRDAI's issued guidelines for a standard health cover policy. The product is specially designed to ensure that quality healthcare remains accessible and affordable to millions of people in India, especially in times when medical expenses are getting beyond everyone's reach.

'Arogya Sanjeevani Policy, ManipalCigna' is a simplified product that provides an essential health cover of Rs 1 lakh to Rs 5 lakhs for medical treatment of illnesses and injuries requiring in-patient hospitalization including for infectious diseases like Coronavirus (Covid-19) or similar such diseases and also provides cover for listed modern treatments & procedures. In addition, the product offers pre- hospitalization, post-hospitalization, AYUSH treatment, all day-care treatments, road ambulance, cumulative bonus in case of no claim and medical expenses if the insured undergoes a cataract surgery. The product also provides a family discount of 15% for covering 2 and more family members under the single individual policy to make it more affordable for families. There is an additional Online Renewal Discount of 3% p.a. from first renewal onwards, if the premium is received through NACH or Standing Instruction (where payment is made either by direct debit of bank account or credit card).

Speaking about the product launch, Prasun Sikdar, Managing Director and CEO, ManipalCigna Health Insurance Company Limited said, "Considering the growing medical inflation, and the rising infectious diseases like Coronavirus (Covid-19), having a health insurance coverage is a necessity for every individual and family. It's important for us to be prepared in advance and a safety net of health insurance coverage for yourself and family gives us protection against the medical expenses of the future. Our Arogya Sanjeevani, ManipalCigna Policy, could be a good choice for the first-time health insurance buyers in India as the policy is designed to provide access to quality health care while safeguarding your financial well-being."

Hospitalisation is a testing time for all and looking at the soaring healthcare costs, the product covers necessary hospitalization expenses incurred at any medical facility registered with ManipalCigna's network in India and even in non-network hospitals. It also covers the expenses incurred towards - dental treatment or plastic surgery necessitated due to disease or injury. Additionally, the policyholder will be provided a grace period of up to 30 days, for a yearly mode of payment. In case of a free-look period - the insured shall be allowed a period of fifteen days from date of receipt of the policy to review the terms and conditions of the policy, and to return the same if not acceptable.

Tags : #manipalcignahealthinsurance #covid-19treatment #arogyasanjeevanipolicy #moderntreatment

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

CARE Hospitals to Offer Free Vascular Health Check on National Vascular DayAugust 05, 2026
Breastfeeding Myths That New Mothers Should Stop BelievingAugust 05, 2026
Why Modern Lifestyle Causes Chronic InflammationAugust 05, 2026
Endometriosis Awareness: Understanding the Silent Condition Affecting Millions of Indian WomenAugust 05, 2026
A Complete Guide to Pregnancy Health Tips for Indian Women: Nutrition, Wellness, and What Every Expectant Mother Should KnowAugust 05, 2026
Metropolis Healthcare reports strong Q1FY27 performance, with revenue up 17% to ₹450 crore and EBITDA up 27% YoYAugust 04, 2026
India's Silent Liver Health Crisis: New Data Points to Urgent Need for Screening and PreventionAugust 04, 2026
Eureka Forbes Launches 'Ghar Ka New Favourite' Campaign showcasing Forbes SmartClean Robotic Vacuum Cleaner with Shraddha KapoorAugust 04, 2026
Why Preventive Healthcare for Children Is One of the Most Important Investments India Can MakeAugust 04, 2026
The Role of Pathology in Healthcare: From Diagnosis to Disease PreventionAugust 04, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 04, 2026
Comprehensive Evaluation of Syncope: Cardiac vs. Neurological Origin WorkupsAugust 04, 2026
Common Medical Terms Explained: A Plain-Language Guide for Indian Patients and Healthcare SeekersAugust 03, 2026
Why Radiology Is the Backbone of Modern Medical Diagnosis and TreatmentAugust 03, 2026
Managing Urban Stress: Science-Backed Strategies for Mental Resilience in 2026 August 01, 2026
Managing Chronic Inflammation: The Role of Anti-Inflammatory Indian SuperfoodsAugust 01, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 01, 2026
Early Markers of Glaucoma: Structural vs. Functional Ophthalmic Diagnostic ProtocolsAugust 01, 2026
Managing Complex Diabetic Foot Ulcers: Multidisciplinary Wound Care, Offloading, and RevascularizationAugust 01, 2026
The Future of Preventive Medicine: How India Is Moving From Cure to PreventionAugust 01, 2026